Health Professional Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Professional Times.

Press releases published on May 12, 2026

May 12, 2026

TeleSpecialists Expands Digital Healthcare Access Across Rural Communities Nationwide

Indeterminate GlobeNewswire

May 12, 2026

Truveta and Knit Health announce collaboration to power a new generation of clinical AI

Indeterminate GlobeNewswire

May 12, 2026

LiveWorld's New APP Research Council Gives Brands Direct Access to Frontline NP and PA Insights to Improve Relevance, Reach, and ROI

Indeterminate GlobeNewswire

May 12, 2026

Mental Health Awareness Month: TPN.health Solves the Access Crisis Costing Self-Insured Stakeholders, Health Plans and Members the Care They Deserve

Indeterminate GlobeNewswire

May 12, 2026

Becker’s Names Leap Distributors CEO Allen Mason to 2026 Great Leaders in Healthcare List

Indeterminate GlobeNewswire

May 12, 2026

Kura Oncology and Kyowa Kirin to Present Updated Frontline Ziftomenib / 7+3 Combination Data at EHA 2026 Congress

Indeterminate GlobeNewswire

May 12, 2026

Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree

Indeterminate GlobeNewswire

May 12, 2026

Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease

Indeterminate GlobeNewswire

May 12, 2026

First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026 

Indeterminate GlobeNewswire

May 12, 2026

Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress

Indeterminate GlobeNewswire

May 12, 2026

Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress

Indeterminate GlobeNewswire

May 12, 2026

Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress

Indeterminate GlobeNewswire

May 12, 2026

Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual Meeting

Indeterminate GlobeNewswire

May 12, 2026

BlossomHill Therapeutics to Present Initial Clinical Dose Escalation Data from the Phase 1/1b Trial of BH-30236 in Patients with R/R AML or HR-MDS at EHA2026

Indeterminate GlobeNewswire

May 12, 2026

Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias

Indeterminate GlobeNewswire

May 12, 2026

Ajax Therapeutics Announces Oral Presentation of Clinical Results from AJX-101, a Phase I study of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the European Hematology Society (EHA) 2026 Congress

Indeterminate GlobeNewswire

May 12, 2026

Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress

Indeterminate GlobeNewswire

May 12, 2026

Cellectis présentera des données cliniques sur lasmé-cel et éti-cel au congrès annuel de l’EHA 2026

Indeterminate GlobeNewswire

May 12, 2026

Independent Cleveland Clinic Review Finds No Clinically Significant Cardiotoxicity with Moleculin's Annamycin in R/R AML Patients Dosed Beyond Conventional Anthracycline Limits

Indeterminate GlobeNewswire

May 12, 2026

PayZen Report: Healthcare Financial Pressures Mount as 73% of Systems Elevate Patient Payment Balances to a Top Priority

Indeterminate GlobeNewswire